1 The National Institute of Neurological Disorders and

Stroke rt-PA Stroke Study Group. Tissue plasminogen

activator for acute ischemic stroke[J]. N Engl J Med,

1995, 333:1581-1587.

2 Adams HP, Jr, del Zoppo G, Alber ts MJ, et al.

Guidelines for the early management of adults with

ischemic stroke:a guideline from the American

Heart Association/American Stroke Association

Stroke Council, Clinical Cardiology Council,

Cardiovascular Radiology and Intervention Council,

and the Atheroscle rot ic Per ipheral Vascular

Disease and Quality of Care Outcomes in Research

Interdisciplinary Working Groups:The AmericanAcademy of Neurology affirms the value of this

guideline as an educational tool for neurologists[J].

Circulation, 2007, 115:e478-e534.

3 Hacke W, Kaste M, Bluhmki E, et al. Thrombolysis

with alteplase 3 to 4.5 hours after acute ischemic

stroke[J]. N Engl J Med, 2008, 359:1317-1329.

4 中华医学会神经病学分会脑血管病学组. 2010年中国

急性缺血性脑卒中诊治指南[J]. 中国临床医师, 2011,

3:67-73.

5 中华医学会神经病学分会脑血管病学组急性缺血性

脑卒中诊治指南撰写组. 中国急性缺血性脑卒中诊治

指南2010[J]. 中华神经科杂志, 2010, 43:146-153.

6 Behrouz R. Intravenous tenecteplase in acute ischemic

stroke:an updated review[J]. J Neurol, 2014, 261:1069-

1072.

7 Belkouch A, Jidane S, Chouaib N, et al. Thrombolysis

for acute ischemic stroke by tenecteplase in the

emergency department of a Moroccan hospital[J]. Pan

Afr Med J, 2015, 21:37.

8 郑天衡, 王少石. 急性脑梗死的血管再通治疗[J]. 内科

急危重症杂志, 2012, 18:7-10.

9 Wa h lg r en N, A hmed N, D ava l os A , e t a l .

Thrombolysis with alteplase for acute ischaemic stroke

in the Safe Implementation of Thrombolysis in Stroke-

Monitoring Study (SITS-MOST):an observational

study[J]. Lancet, 2007, 369:275-282.

10 Wardlaw JM, Carpenter T, Sakka E, et al. Imaging

perfusion deficits, arterial patency and thrombolysis

safety and efficacy in acute ischaemic stroke:An

observational study of the effect of advanced imaging

methods in The Third International Stroke Trial (IST-

3), a randomised controlled trial. Southampton (UK)

[J]. Southampton (UK):NIHR Journals Library, 2014

Jul.

11 Kimura K, Aoki J, Sakamoto Y, et al. Administration

of edaravone, a free radical scavenger, during t-PA

infusion can enhance early recanalization in acute

stroke patients--a preliminary study[J]. J Neurol Sci,

2012, 313:132-136.

12 Kono S, Deguchi K, Morimoto N, et al. Intravenous

thrombolysis with neuroprotective therapy by

edaravone for ischemic stroke patients older than

80 years of age[J]. J Stroke Cerebrovasc Dis, 2013,

22:1175-1183.

13 Lapchak PA. A critical assessment of edaravone

acute ischemic stroke efficacy trials:is edaravone an

effective neuroprotective therapy?[J]. Expert Opin

Pharmacother, 2010, 11:1753-1763.

14 Takenaka K, Kato M, Yamauti K, et al. Simultaneous

administration of recombinant tissue plasminogenactivator and edaravone in acute cerebral ischemic

stroke patients[J]. J Stroke Cerebrovasc Dis, 2014,

23:2748-2752.

15 Del Zoppo GJ, Higashida RT, Furlan AJ, et al.

PROACT:a phase II randomized trial of recombinant

pro-urokinase by direct arterial delivery in acute

middle cerebral artery stroke. PROACT Investigators.

Prolyse in Acute Cerebral Thromboembolism[J].

Stroke, 1998, 29:4-11.

16 Furlan A, Higashida R, Wechsler L, et al. Intraarterial

prourokinase for acute ischemic stroke. The

PROACT II study:a randomized controlled trial.

Prolyse in Acute Cerebral Thromboembolism[J].

JAMA, 1999, 282:2003-2011.

17 Lee M, Hong KS, Saver JL. Efficacy of intra-arterial

fibrinolysis for acute ischemic stroke:meta-analysis of

randomized controlled trials[J]. Stroke, 2010, 41:932-937.

18 IMS Study Investigators. Combined intravenous

and intra-arterial recanalization for acute ischemic

stroke:the Interventional Management of Stroke

Study[J]. Stroke, 2004, 35:904-911.

19 IMS II Trial Investigators. The Interventional

Management of Stroke (IMS) II Study[J]. Stroke,

2007, 38:2127-2135.

20 Mazighi M, Meseguer E, Labreuche J, et al. Bridging

therapy in acute ischemic stroke:a systematic review

and meta-analysis[J]. Stroke, 2012, 43:1302-1308.

21 Nogueira RG, Lutsep HL, Gupta R, et al. Trevo versus

Merci retrievers for thrombectomy revascularisation

of large vessel occlusions in acute ischaemic stroke

(TREVO 2):a randomised trial[J]. Lancet, 2012,

380:1231-1240.

22 Hann S, Chalouhi N, Starke R, et al. Comparison of

neurologic and radiographic outcomes with Solitaire

versus Merci/Penumbra systems for acute stroke

intervention[J]. Biomed Res Int, 2013, 2013:715170.

23 Berkhemer OA, Fransen PS, Beumer D, et al. A

randomized trial of intraarterial treatment for acute

ischemic stroke[J]. N Engl J Med, 2015, 372:11-20.

24 Goyal M, Demchu k AM, Menon BK, e t a l .

Randomized assessment of rapid endovascular

treatment of ischemic stroke[J]. N Engl J Med, 2015,

372:1019-1030.

25 Campbell BC, Mitchell PJ, Kleinig TJ, et al.

Endovascular therapy for ischemic stroke with

perfusion-imaging selection[J]. N Engl J Med, 2015,

372:1009-1018.

26 Saver JL, Goyal M, Bonafe A, et al. Stent-retriever

thrombectomy after intravenous t-PA vs t-PA alone in

stroke[J]. N Engl J Med, 2015, 372:2285-2295.